Healthstream (HSTM) Receivables (2010 - 2026)

Healthstream (HSTM) has 17 years of Receivables data on file, last reported at $43.4 million in Q1 2026.

• Receivables for Q1 2026 came in at $43.4 million, up 20.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.4 million (up 20.39% YoY), and the FY2025 annual result was $39.0 million, up 10.41% from the prior year.
• Receivables rose to $43.4 million in Q1 2026 per HSTM's latest filing, from $39.0 million in the prior quarter.
• Over five years, Receivables peaked at $47.3 million in Q1 2023 and troughed at $31.5 million in Q2 2025.
• A 5-year average of $37.9 million and a median of $36.2 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2025: Receivables climbed 22.31% in 2022, then retreated 18.08% in 2025.
• A 5-year view of Receivables shows it stood at $42.7 million in 2022, then fell by 9.98% to $38.4 million in 2023, then dropped by 8.13% to $35.3 million in 2024, then climbed by 10.41% to $39.0 million in 2025, then advanced by 11.4% to $43.4 million in 2026.
• Business Quant data shows HSTM's Receivables at $43.4 million in Q1 2026, $39.0 million in Q4 2025, and $33.7 million in Q3 2025.